Description
The RS-DSC is for preclinical development of antibodies, antibody-drug conjugates, and vaccines where dosage forms are typically greater than 50 µg. The RS-DSC offers researchers high throughput capabilities of short term thermal stability, true label-free analysis of samples, and requires low sample volumes. To increase ease of use and reduce sample carryover effects between experiments, disposable microfluidic devices to contain the sample during measurement are used and then discarded after each test. The software to analyze and organize the data sets is integral to enabling accurate and timely decision making.
